Judith Koch1, Thomas Harder, Rüdiger von Kries, Ole Wichmann. 1. Immunization Unit, Robert Koch Institute Berlin, Robert Koch Institute Berlin; Institute of Social Paediatrics and Adolescent Medicine, Ludwig-Maximilians-Universität München.
Abstract
BACKGROUND: In 2013, the German Standing Committee on Vaccination (Ständige Impfkommission, STIKO) recommended rotavirus (RV) vaccination for all infants while stating that this mildly increased the risk of intussusception, a potentially life-threatening event. Since this recommendation was issued, multiple observational studies on this topic designed as self-controlled case series (SCCS) have been published. The SCCS design is particularly suitable for the study of rare adverse effects of medications. METHODS: We systematically searched the literature for SCCS studies on the risk of intussusception after RV vaccination. Relative risks (RR) corresponding to different doses of vaccine were summarized in a meta-analysis, and attributable risks (AR) were calculated. RESULTS: Of the 16 initially identified studies, 10 with a predominantly low risk of bias were considered in the analysis. The RR for intussusception was 5.71 (95% confidence interval [4.50; 7.25]) 1-7 days after the first dose, 1.69 [1.33; 2.14] after the second, and 1.14 [0.75; 1.74] after the third. The AR for children of the age at which RV vaccination is recommended was 1.7 [1.1; 2.7] additional intussusceptions per 100 000 vaccinated children after the first dose and 0.25 [0.16; 0.40] after the second. If >3-month-old infants are vaccinated, the AR is higher: 5.6 [4.3; 7.2] per 100 000 after the first dose and 0.81 [0.63; 1.06] per 100 000 after the second. CONCLUSION: RV vaccination is associated with a markedly elevated RR and a mildly elevated AR for intussusception 1-7 days after the first dose. Physicians should begin the series of vaccinations at age 6-12 weeks, as recommended by the STIKO, because the risk of intussusception is higher afterward. Current health insurance company claim data indicate that 11.2% of infants are still receiving the first dose of the vaccine at ages above 3 months. The parents of vaccinated children should be informed about the possible signs of intussusception (colicky pain, bilious vomiting, and red "currant jelly" stool).
BACKGROUND: In 2013, the German Standing Committee on Vaccination (Ständige Impfkommission, STIKO) recommended rotavirus (RV) vaccination for all infants while stating that this mildly increased the risk of intussusception, a potentially life-threatening event. Since this recommendation was issued, multiple observational studies on this topic designed as self-controlled case series (SCCS) have been published. The SCCS design is particularly suitable for the study of rare adverse effects of medications. METHODS: We systematically searched the literature for SCCS studies on the risk of intussusception after RV vaccination. Relative risks (RR) corresponding to different doses of vaccine were summarized in a meta-analysis, and attributable risks (AR) were calculated. RESULTS: Of the 16 initially identified studies, 10 with a predominantly low risk of bias were considered in the analysis. The RR for intussusception was 5.71 (95% confidence interval [4.50; 7.25]) 1-7 days after the first dose, 1.69 [1.33; 2.14] after the second, and 1.14 [0.75; 1.74] after the third. The AR for children of the age at which RV vaccination is recommended was 1.7 [1.1; 2.7] additional intussusceptions per 100 000 vaccinated children after the first dose and 0.25 [0.16; 0.40] after the second. If >3-month-old infants are vaccinated, the AR is higher: 5.6 [4.3; 7.2] per 100 000 after the first dose and 0.81 [0.63; 1.06] per 100 000 after the second. CONCLUSION: RV vaccination is associated with a markedly elevated RR and a mildly elevated AR for intussusception 1-7 days after the first dose. Physicians should begin the series of vaccinations at age 6-12 weeks, as recommended by the STIKO, because the risk of intussusception is higher afterward. Current health insurance company claim data indicate that 11.2% of infants are still receiving the first dose of the vaccine at ages above 3 months. The parents of vaccinated children should be informed about the possible signs of intussusception (colicky pain, bilious vomiting, and red "currant jelly" stool).
Authors: F Raúl Velázquez; Romulo E Colindres; Concepción Grajales; M Teresa Hernández; María Guadalupe Mercadillo; F Javier Torres; MariaYolanda Cervantes-Apolinar; Rodrigo DeAntonio-Suarez; Eduardo Ortega-Barria; Maxim Blum; Thomas Breuer; Thomas Verstraeten Journal: Pediatr Infect Dis J Date: 2012-07 Impact factor: 2.129
Authors: Irene M Shui; James Baggs; Manish Patel; Umesh D Parashar; Melisa Rett; Edward A Belongia; Simon J Hambidge; Jason M Glanz; Nicola P Klein; Eric Weintraub Journal: JAMA Date: 2012-02-08 Impact factor: 56.272
Authors: W Katherine Yih; Tracy A Lieu; Martin Kulldorff; David Martin; Cheryl N McMahill-Walraven; Richard Platt; Nandini Selvam; Mano Selvan; Grace M Lee; Michael Nguyen Journal: N Engl J Med Date: 2014-01-14 Impact factor: 91.245
Authors: Penina Haber; Manish Patel; Hector S Izurieta; James Baggs; Paul Gargiullo; Eric Weintraub; Margaret Cortese; M Miles Braun; Edward A Belongia; Elaine Miller; Robert Ball; John Iskander; Umesh D Parashar Journal: Pediatrics Date: 2008-06 Impact factor: 7.124
Authors: Max Ciarlet; Ramei Sani-Grosso; Guojun Yuan; Guanghan F Liu; Penny M Heaton; Keith M Gottesdiener; José L Arredondo; Florian Schödel Journal: Pediatr Infect Dis J Date: 2008-10 Impact factor: 2.129
Authors: J Bradley Layton; Anne M Butler; Catherine A Panozzo; M Alan Brookhart Journal: Paediatr Perinat Epidemiol Date: 2018-07-26 Impact factor: 3.980